Adapt Gold Standard CE-SDS Workflows to Meet New Demands in Biopharmaceutical Development

The pressure is on. The platform is ready. Adapt gold standard capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) workflows to meet new demands. Learn how to migrate protein purity assays to a higher throughput platform.

Register Free: https://www.biopharminternational.com/bp_w/meet-new-demands

Event Overview:

In the competitive landscape of biopharmaceutical development, maintaining a robust analytical portfolio is essential to support the diverse, evolving architectures of therapeutic proteins and to maintain project timelines. While protein purity analysis is standardized with analysis by CE-SDS, not all molecules conform to platform-based methodologies, necessitating flexible, off-platform method development for accurate characterization.
In this webinar, we will explore various CE-SDS method advancements for sample throughput, as well as practical strategies for method transfer between the multicapillary BioPhase 8800 system and the single-capillary PA 800 Plus system.

Key Learning Objectives:

• Learn how to adapt platform technologies to new modalities
• Optimize method development to maintain project timelines
• Explore how to transfer SOPs to new technology

Who Should Attend:

• Lab directors
• Analytical scientists
• QC scientists

LSD. More technical parts of the talk will showcase why detector settings like the evaporation temperature drive application versatility, and how the power function affects linearity and response curves.

Key Learning Objectives:

• Learn about the benefits of using charged aerosol detection for impurity analysis
• Learn about key parameters to get higher quantitative accuracy in your results
• Experience new product developments by the inventors of charged aerosol detection technology

Speaker:

Peter Holper
Staff Applications Scientist
SCIEX

Peter Holper has over 15 years of experience in biopharma, including his role as an analytical chemist at Eli Lilly and Company where he was responsible for developing the analytical control strategy for bioproducts. He has extensive experience in analytical method development for biologics and held various positions with increasing responsibility. Holper works at SCIEX as a staff applications scientist in Redwood City, California, where he is responsible for developing and optimizing CE applications and providing customer demo sample analysis support.


Register Free: https://www.biopharminternational.com/bp_w/meet-new-demands